People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Biodel Inc | — | Pharmaceuticals | Series B | $18.5M | $629.1M | 2012 |
Daniel W. Lorber at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel W. Lorber on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian J. G. Pereira | 1 | 2 |
| Errol B De Souza | 1 | 2 |
| Alan S. Krasner | 1 | 1 |
| Davey S. Scoon | 1 | 1 |
| Gerard J. Michel | 1 | 1 |
| Paul S. Bavier | 1 | 1 |
| Julie R. Brown | 1 | 1 |
| Barry S. Ginsberg | 1 | 1 |
| Ira W. Lieberman | 1 | 1 |
| Erik S. Steiner | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.